Last 48 quarters of trend data · Healthcare · Specialty & Generic Drugs
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 25.50 | 75.40 | 24.99 | 10.53 | 20.29 | 31.27 | 18.27 | 23.92 | — | 15.33 | 22.81 | 8.32 | 10.54 | 9.24 | 15.77 | — | — | 20.44 | 27.06 | 22.67 | — |
| — | +141.1% | +36.7% | -56.0% | — | +104.0% | -19.9% | +187.5% | — | +65.9% | +44.6% | — | — | -54.8% | -41.7% | — | — | — | — | -44.8% | — | |
| P/S Ratio | 4.19 | 4.37 | 4.82 | 3.31 | 2.71 | 2.26 | 3.81 | 4.68 | 3.96 | 5.29 | 3.60 | 2.95 | 3.07 | 3.80 | 4.63 | 4.65 | 3.32 | 5.22 | 5.22 | 4.64 | 3.77 |
| — | +93.2% | +26.7% | -29.3% | -31.5% | -57.3% | +5.8% | +58.7% | +29.0% | +39.2% | -22.4% | -36.6% | -7.5% | -27.2% | -11.3% | +0.3% | -12.1% | +22.8% | +13.2% | +18.6% | +57.6% | |
| P/B Ratio | 6.32 | 5.02 | 5.71 | 4.12 | 4.05 | 3.10 | 4.93 | 5.99 | 5.69 | 6.80 | 5.52 | 4.61 | 5.33 | 6.96 | 10.78 | 12.55 | 7.81 | 7.83 | 8.24 | 7.51 | 4.21 |
| — | +62.0% | +15.8% | -31.3% | -28.8% | -54.4% | -10.7% | +29.8% | +6.9% | -2.4% | -48.8% | -63.2% | -31.8% | -11.1% | +30.9% | +67.2% | +85.3% | +125.3% | +124.4% | +174.1% | +140.1% | |
| P/FCF | 16.66 | 17.04 | 20.84 | 10.23 | 13.56 | 9.16 | 19.52 | 17.64 | 11.13 | 12.59 | 19.27 | 9.17 | 10.84 | 11.91 | — | 14.08 | 8.67 | 14.29 | 17.12 | 136.93 | 52.33 |
| — | +85.9% | +6.8% | -42.0% | +21.7% | -27.2% | +1.3% | +92.4% | +2.7% | +5.7% | — | -34.9% | +25.0% | -16.6% | — | -89.7% | -83.4% | -93.7% | -14.8% | +176.2% | -58.6% | |
| EV / EBITDA | 17.83 | 28.04 | 15.31 | 12.30 | 11.82 | 14.48 | 14.02 | 14.37 | 11.24 | 12.88 | 11.76 | 9.20 | 6.97 | 9.58 | 10.97 | 270.64 | — | 12.57 | 15.56 | 13.93 | — |
| — | +93.6% | +9.2% | -14.4% | +5.1% | +12.4% | +19.2% | +56.2% | +61.4% | +34.4% | +7.2% | -96.6% | — | -23.8% | -29.5% | +1842.2% | — | — | — | -15.2% | — | |
| EV / EBIT | 21.91 | 57.82 | 19.05 | 7.93 | 15.67 | 19.58 | 12.97 | 16.41 | 346.01 | 10.73 | 15.49 | 6.05 | 7.41 | 7.38 | 11.93 | — | — | 14.54 | 18.46 | 16.59 | — |
| — | +195.3% | +46.9% | -51.7% | -95.5% | +82.5% | -16.3% | +171.2% | +4572.5% | +45.5% | +29.9% | — | — | -49.3% | -35.4% | — | — | — | — | -27.4% | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 61.1% | 62.4% | 62.3% | 61.2% | 59.2% | 57.9% | 63.8% | 63.8% | 63.5% | 63.9% | 64.9% | 68.1% | 64.9% | 62.5% | 63.0% | 25.6% | 63.5% | 61.6% | 61.7% | 61.8% | 44.7% |
| — | +7.8% | -2.3% | -4.0% | -6.8% | -9.4% | -1.8% | -6.3% | -2.1% | +2.3% | +3.0% | +165.6% | +2.2% | +1.4% | +2.1% | -58.5% | +42.1% | +47.4% | +35.3% | +39.3% | +8.9% | |
| Operating Margin | 20.2% | 8.3% | 25.8% | 21.6% | 19.0% | 11.4% | 23.3% | 27.4% | 29.1% | 35.3% | 26.1% | 27.1% | 38.8% | 35.1% | 38.6% | -3.1% | -65.2% | 35.8% | 28.3% | 28.2% | -27.3% |
| — | -27.3% | +10.9% | -21.3% | -34.8% | -67.8% | -10.7% | +0.9% | -25.0% | +0.6% | -32.4% | +973.4% | +159.5% | -2.0% | +36.6% | -111.0% | -139.2% | +355.3% | +206.6% | +67.1% | -4763.6% | |
| Net Margin | 15.2% | 5.7% | 19.3% | 31.4% | 13.3% | 7.2% | 20.8% | 19.6% | -3.0% | 34.6% | 15.8% | 35.4% | 29.2% | 41.2% | 29.3% | -0.9% | -45.3% | 25.6% | 19.2% | 20.6% | -31.0% |
| — | -20.7% | -7.2% | +60.4% | +541.1% | -79.1% | +32.3% | -44.8% | -110.3% | -16.1% | -46.2% | +3896.1% | +164.5% | +61.2% | +52.0% | -104.5% | -45.9% | +294.7% | +173.0% | +111.2% | -756.5% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 21.4% | 1.7% | 5.9% | 10.3% | 4.9% | 2.4% | 6.8% | 6.5% | -1.0% | 11.9% | 6.3% | 14.9% | 13.7% | 21.1% | 18.9% | -0.6% | -22.0% | 10.2% | 8.0% | 8.8% | -8.3% |
| — | -31.0% | -12.0% | +58.8% | +571.0% | -79.6% | +7.3% | -56.5% | -107.6% | -43.7% | -66.6% | +2466.3% | +162.1% | +107.6% | +137.2% | -107.2% | -163.2% | +481.5% | +254.5% | +407.1% | -1156.8% | |
| ROA | 11.1% | 0.9% | 3.2% | 5.2% | 2.4% | 1.3% | 3.8% | 3.6% | -0.6% | 6.6% | 3.3% | 7.5% | 6.5% | 9.2% | 7.0% | -0.2% | -9.9% | 5.8% | 4.4% | 4.8% | -4.7% |
| — | -27.4% | -16.5% | +43.2% | +510.5% | -80.8% | +14.7% | -52.0% | -109.0% | -28.8% | -53.0% | +3681.0% | +166.1% | +59.0% | +58.4% | -104.4% | -109.9% | +469.0% | +241.1% | +354.7% | -1104.6% | |
| ROIC | 21.7% | 2.3% | 5.6% | 4.4% | 4.2% | 2.7% | 6.8% | 9.4% | 9.9% | 11.0% | 8.9% | 9.6% | 14.5% | 11.8% | 14.5% | -1.2% | -21.8% | 11.2% | 8.1% | 7.8% | -4.6% |
| — | -12.8% | -18.2% | -52.5% | -57.6% | -75.7% | -23.0% | -2.7% | -31.9% | -6.5% | -38.5% | +906.1% | +166.5% | +4.9% | +77.5% | -115.4% | -370.8% | +717.4% | +350.8% | +333.9% | -7621.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.57 | 0.04 | 0.48 | 0.52 | 0.62 | 0.55 | 0.53 | 0.53 | 0.57 | 0.52 | 0.60 | 0.65 | 0.76 | 0.88 | 1.07 | 1.31 | 1.30 | 0.29 | 0.33 | 0.33 | 0.41 |
| — | -92.8% | -9.7% | -2.2% | +8.5% | +5.4% | -12.4% | -19.2% | -24.7% | -40.4% | -43.7% | -50.2% | -42.1% | +207.6% | +227.0% | +292.4% | +216.8% | -19.2% | -7.5% | -3.0% | -10.2% | |
| Debt / EBITDA | 1.63 | 0.98 | 5.09 | 6.02 | 6.73 | 9.68 | 6.08 | 5.31 | 4.72 | 4.11 | 5.26 | 5.33 | 4.05 | 4.85 | 4.22 | 110.75 | — | 1.87 | 2.46 | 2.44 | — |
| — | -89.9% | -16.3% | +13.3% | +42.5% | +135.6% | +15.7% | -0.4% | +16.7% | -15.3% | +24.5% | -95.2% | — | +159.6% | +71.5% | +4446.4% | — | — | — | -68.2% | — | |
| Current Ratio | 2.70 | 3.25 | 3.06 | 2.83 | 2.70 | 2.67 | 4.29 | 5.74 | 5.52 | 1.65 | 4.68 | 4.84 | 5.80 | 5.37 | 4.88 | 2.80 | 2.74 | 2.13 | 1.85 | 1.83 | 2.61 |
| — | +21.8% | -28.7% | -50.7% | -51.1% | +61.4% | -8.3% | +18.5% | -4.8% | -69.2% | -4.2% | +73.1% | +111.9% | +152.5% | +164.4% | +53.1% | +5.0% | -18.8% | -26.8% | -29.9% | +13.9% | |
| Quick Ratio | 2.51 | 3.06 | 2.89 | 2.64 | 2.51 | 2.49 | 4.07 | 5.46 | 5.23 | 1.56 | 4.41 | 4.55 | 5.45 | 5.05 | 4.55 | 2.65 | 2.59 | 1.98 | 1.69 | 1.64 | 2.22 |
| — | +23.1% | -29.0% | -51.6% | -52.1% | +59.3% | -7.7% | +20.1% | -4.1% | -69.1% | -3.0% | +72.0% | +110.4% | +155.2% | +168.8% | +61.8% | +16.9% | -9.2% | -19.2% | -23.5% | +20.2% | |
| Interest Coverage | 16.89 | 5.41 | 20.09 | 33.16 | 14.86 | 9.56 | 22.26 | 21.09 | 0.84 | 36.92 | 18.35 | 36.25 | 28.46 | 32.65 | 26.07 | -1.22 | -67.28 | 52.06 | 43.24 | 39.37 | -25.84 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying LNTH stock.
Lantheus Holdings, Inc.'s current P/E is 25.5x. The average P/E over the last 4 quarters is 32.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Lantheus Holdings, Inc.'s current operating margin is 20.2%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Lantheus Holdings, Inc.'s business trajectory between earnings reports.